Selected research
Industry Growth & Trends
Global Adeno Associated Virus Production Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Adeno Associated Virus Production market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Adeno Associated Virus Production is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Adeno Associated Virus Production is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Adeno Associated Virus Production is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Adeno Associated Virus Production market include Biovian, Charles River, Lonza, Merck Group, OriGene, Sigma-Aldrich, SIRION Biotech, Thermo Fisher Scientific and Vigene Biosciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Adeno Associated Virus Production market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Adeno Associated Virus Production market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Adeno Associated Virus Production market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Adeno Associated Virus Production.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Adeno Associated Virus Production market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Adeno Associated Virus Production Market by Company
Biovian
Charles River
Lonza
Merck Group
OriGene
Sigma-Aldrich
SIRION Biotech
Thermo Fisher Scientific
Vigene Biosciences
Yeasen Aav
Adeno Associated Virus Production Segment by Type
Large-Scale Production
Customized Production
Adeno Associated Virus Production Segment by Application
Vaccine Production
Gene Therapy
Others
Adeno Associated Virus Production Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Adeno Associated Virus Production market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Adeno Associated Virus Production and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Adeno Associated Virus Production.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Adeno Associated Virus Production companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Large-Scale Production
- Customized Production
Applications
- Vaccine Production
- Gene Therapy
- Others
Companies covered
- Biovian
- Charles River
- Lonza
- Merck Group
- OriGene
- Sigma-Aldrich
- SIRION Biotech
- Thermo Fisher Scientific
- Vigene Biosciences
- Yeasen Aav
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Adeno Associated Virus Production Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Adeno Associated Virus Production Market Size by Region (2021-2032)
- 1.4.1 Global Adeno Associated Virus Production Market Size by Region (2021-2026)
- 1.4.2 Global Adeno Associated Virus Production Market Size by Region (2027-2032)
- 1.5 Key Regions Adeno Associated Virus Production Market Size (2021-2032)
- 1.5.1 North America Adeno Associated Virus Production Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Adeno Associated Virus Production Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Adeno Associated Virus Production Market Size Growth Rate (2021-2032)
- 1.5.4 South America Adeno Associated Virus Production Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Adeno Associated Virus Production Market Size Growth Rate (2021-2032)
2 Adeno Associated Virus Production Market by Type
- 2.1 Type Introduction
- 2.1.1 Large-Scale Production
- 2.1.2 Customized Production
- 2.2 Global Adeno Associated Virus Production Market Size by Type
- 2.2.1 Global Adeno Associated Virus Production Market Size Overview by Type (2021-2032)
- 2.2.2 Global Adeno Associated Virus Production Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Adeno Associated Virus Production Market Size Forecasted by Type (2027-2032)
- 2.3 Global Adeno Associated Virus Production Market Size by Regions
- 2.3.1 North America Adeno Associated Virus Production Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Adeno Associated Virus Production Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Adeno Associated Virus Production Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Adeno Associated Virus Production Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Adeno Associated Virus Production Market Size Breakdown by Type (2021-2026)
3 Adeno Associated Virus Production Market by Application
- 3.1 Type Introduction
- 3.1.1 Vaccine Production
- 3.1.2 Gene Therapy
- 3.1.3 Others
- 3.2 Global Adeno Associated Virus Production Market Size by Application
- 3.2.1 Global Adeno Associated Virus Production Market Size Overview by Application (2021-2032)
- 3.2.2 Global Adeno Associated Virus Production Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Adeno Associated Virus Production Market Size Forecasted by Application (2027-2032)
- 3.3 Global Adeno Associated Virus Production Market Size by Regions
- 3.3.1 North America Adeno Associated Virus Production Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Adeno Associated Virus Production Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Adeno Associated Virus Production Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Adeno Associated Virus Production Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Adeno Associated Virus Production Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Adeno Associated Virus Production Industry Trends
- 4.2 Adeno Associated Virus Production Industry Drivers
- 4.3 Adeno Associated Virus Production Industry Opportunities and Challenges
- 4.4 Adeno Associated Virus Production Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Adeno Associated Virus Production Revenue (2021-2026)
- 5.2 Global Adeno Associated Virus Production Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Adeno Associated Virus Production Key Company Headquarters & Area Served
- 5.4 Global Adeno Associated Virus Production Company, Product Type & Application
- 5.5 Global Adeno Associated Virus Production Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Adeno Associated Virus Production Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Adeno Associated Virus Production Players Market Share by Revenue in 2025
- 5.6.3 2025 Adeno Associated Virus Production Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Biovian
- 6.1.1 Biovian Company Information
- 6.1.2 Biovian Business Overview
- 6.1.3 Biovian Adeno Associated Virus Production Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Biovian Adeno Associated Virus Production Product Portfolio
- 6.1.5 Biovian Recent Developments
- 6.2 Charles River
- 6.2.1 Charles River Company Information
- 6.2.2 Charles River Business Overview
- 6.2.3 Charles River Adeno Associated Virus Production Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Charles River Adeno Associated Virus Production Product Portfolio
- 6.2.5 Charles River Recent Developments
- 6.3 Lonza
- 6.3.1 Lonza Company Information
- 6.3.2 Lonza Business Overview
- 6.3.3 Lonza Adeno Associated Virus Production Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Lonza Adeno Associated Virus Production Product Portfolio
- 6.3.5 Lonza Recent Developments
- 6.4 Merck Group
- 6.4.1 Merck Group Company Information
- 6.4.2 Merck Group Business Overview
- 6.4.3 Merck Group Adeno Associated Virus Production Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Merck Group Adeno Associated Virus Production Product Portfolio
- 6.4.5 Merck Group Recent Developments
- 6.5 OriGene
- 6.5.1 OriGene Company Information
- 6.5.2 OriGene Business Overview
- 6.5.3 OriGene Adeno Associated Virus Production Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 OriGene Adeno Associated Virus Production Product Portfolio
- 6.5.5 OriGene Recent Developments
- 6.6 Sigma-Aldrich
- 6.6.1 Sigma-Aldrich Company Information
- 6.6.2 Sigma-Aldrich Business Overview
- 6.6.3 Sigma-Aldrich Adeno Associated Virus Production Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Sigma-Aldrich Adeno Associated Virus Production Product Portfolio
- 6.6.5 Sigma-Aldrich Recent Developments
- 6.7 SIRION Biotech
- 6.7.1 SIRION Biotech Company Information
- 6.7.2 SIRION Biotech Business Overview
- 6.7.3 SIRION Biotech Adeno Associated Virus Production Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 SIRION Biotech Adeno Associated Virus Production Product Portfolio
- 6.7.5 SIRION Biotech Recent Developments
- 6.8 Thermo Fisher Scientific
- 6.8.1 Thermo Fisher Scientific Company Information
- 6.8.2 Thermo Fisher Scientific Business Overview
- 6.8.3 Thermo Fisher Scientific Adeno Associated Virus Production Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Thermo Fisher Scientific Adeno Associated Virus Production Product Portfolio
- 6.8.5 Thermo Fisher Scientific Recent Developments
- 6.9 Vigene Biosciences
- 6.9.1 Vigene Biosciences Company Information
- 6.9.2 Vigene Biosciences Business Overview
- 6.9.3 Vigene Biosciences Adeno Associated Virus Production Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Vigene Biosciences Adeno Associated Virus Production Product Portfolio
- 6.9.5 Vigene Biosciences Recent Developments
- 6.10 Yeasen Aav
- 6.10.1 Yeasen Aav Company Information
- 6.10.2 Yeasen Aav Business Overview
- 6.10.3 Yeasen Aav Adeno Associated Virus Production Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Yeasen Aav Adeno Associated Virus Production Product Portfolio
- 6.10.5 Yeasen Aav Recent Developments
7 North America
- 7.1 North America Adeno Associated Virus Production Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Adeno Associated Virus Production Market Size by Country (2021-2026)
- 7.3 North America Adeno Associated Virus Production Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Adeno Associated Virus Production Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Adeno Associated Virus Production Market Size by Country (2021-2026)
- 8.3 Europe Adeno Associated Virus Production Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Adeno Associated Virus Production Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Adeno Associated Virus Production Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Adeno Associated Virus Production Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Adeno Associated Virus Production Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Adeno Associated Virus Production Market Size by Country (2021-2026)
- 10.3 South America Adeno Associated Virus Production Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Adeno Associated Virus Production Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Adeno Associated Virus Production Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Adeno Associated Virus Production Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst